- Home
- SMTC vs AXSM Comparison
SMTC vs AXSM Comparison
Compare SMTC & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTC
- AXSM
- Stock Information
- Founded
- SMTC 1960
- AXSM 2012
- Country
- SMTC United States
- AXSM United States
- Employees
- SMTC N/A
- AXSM N/A
- Industry
- SMTC Semiconductors
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- SMTC Technology
- AXSM Health Care
- Exchange
- SMTC Nasdaq
- AXSM Nasdaq
- Market Cap
- SMTC 3.3B
- AXSM 6.2B
- IPO Year
- SMTC N/A
- AXSM 2015
- Fundamental
- Price
- SMTC $32.71
- AXSM $121.65
- Analyst Decision
- SMTC Strong Buy
- AXSM Strong Buy
- Analyst Count
- SMTC 12
- AXSM 14
- Target Price
- SMTC $67.91
- AXSM $168.64
- AVG Volume (30 Days)
- SMTC 2.5M
- AXSM 825.4K
- Earning Date
- SMTC 03-13-2025
- AXSM 05-05-2025
- Dividend Yield
- SMTC N/A
- AXSM N/A
- EPS Growth
- SMTC N/A
- AXSM N/A
- EPS
- SMTC N/A
- AXSM N/A
- Revenue
- SMTC $851,233,000.00
- AXSM $385,693,000.00
- Revenue This Year
- SMTC $6.56
- AXSM $65.06
- Revenue Next Year
- SMTC $17.74
- AXSM $63.84
- P/E Ratio
- SMTC N/A
- AXSM N/A
- Revenue Growth
- SMTC 0.94
- AXSM 42.53
- 52 Week Low
- SMTC $21.56
- AXSM $64.11
- 52 Week High
- SMTC $79.52
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- SMTC 35.72
- AXSM 51.62
- Support Level
- SMTC $29.98
- AXSM $116.00
- Resistance Level
- SMTC $34.31
- AXSM $128.43
- Average True Range (ATR)
- SMTC 2.74
- AXSM 4.65
- MACD
- SMTC 0.62
- AXSM -2.04
- Stochastic Oscillator
- SMTC 28.09
- AXSM 25.97
About SMTC Semtech Corporation
Semtech Corp is engaged in designing, developing, manufacturing and marketing analog and mixed-signal semiconductors, algorithms and wireless semiconductors, connectivity modules, gateways, routers and connected services for IoT. The company operates in four reportable segments' 1) Signal Integrity, 2) Advanced Protection and Sensing, 3) IoT System and 4) IoT Connected Services. The majority of the company's revenue is earned through Advanced Protection and Sensing Products segment. Geographically majority of the company's revenue is earned from Asia Pacific region.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.